Low-penetrance TP53 variants are mainly hypomorphic: an underestimated issue with high clinical significance
Abstract Missense mutations that inactivate p53 are common in cancer. LiFraumeni syndrome, which is linked to early-onset cancer, is caused by germline mutations in TP53. Full-penetrant, inactive variants have garnered great attention, whereas low-penetrant variants are less well understood despite...
| Published in: | npj Genomic Medicine |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2026-04-01
|
| Online Access: | https://doi.org/10.1038/s41525-026-00568-x |
